Whataroa virus is a mosquitoâÂÂborne RNA virus in the genus Alphavirus (family Togaviridae) first isolated in 1962 near Whataroa in South Westland, New Zealand. It is the only mosquitoâÂÂborne virus known to be endemic to New Zealand and is grouped within the Sindbis virus antigenic complex. The virus circulates in a birdâÂÂmosquito cycle, and human disease has not been confirmed.
Formally described in 1967, Whataroa virus is adapted to South Westland's cool temperate climate and replicates in mosquitoes at comparatively low temperatures for arboviruses. Despite the wide distribution of its main mosquito vectors in New Zealand, documented activity has remained confined to the Whataroa River valley for more than six decades. Closely related isolates were detected in eastern Australia in 1989âÂÂ1990, indicating a wider Australasian presence.
As New Zealand's only endemic mosquitoâÂÂborne virus, it is monitored for publicâÂÂhealth and biosecurity purposes and used as a bioindicator of how exotic viruses might establish and persist.
Whataroa virus is named for the locality of Whataroa, where it was detected during earlyâÂÂ1960s field investigations. In 1962 it was isolated from wild birds and mosquitoes in the Whataroa area during a national survey of arthropodâÂÂborne viruses. It was formally described in 1967 by T. Maguire and J. A. R. Miles, working with virologist J. Casals. They confirmed it as a novel "group A" arbovirus (now Alphavirus) distinct from other known viruses. Serological tests showed that Whataroa virus was antigenically distinct from Sindbis virus, supporting recognition as a separate Alphavirus species.
In modern taxonomy it is placed in the genus Alphavirus, family Togaviridae, and grouped within the Sindbis antigenic complex of the Western equine encephalitis (WEE) complex (also historically called the "Western equine encephalomyelitis" complex) alongside Sindbis, Ockelbo and related viruses. Early phylogenetic analyses of partial E1 and nsP4 sequences placed Whataroa virus with Old World SindbisâÂÂlike viruses within the WEE complex and, unlike New World WEEâÂÂcomplex viruses, found no evidence of the Eastern equine encephalitisâÂÂSindbis recombinant genome arrangement.
Like other alphaviruses, Whataroa virus has an envelope surrounding a capsid that contains a singleâÂÂstranded RNA genome of about 11âÂÂ12 kb. The genome encodes nonâÂÂstructural replication proteins and the structural proteins forming the virion, including envelope glycoproteins E1 and E2. By electron microscopy, virions are roughly spherical (about 70 nm in diameter) with surface spikes formed by repeating E1âÂÂE2 complexes. Australian isolates from New South Wales (1989âÂÂ1990) showed 96âÂÂ97% nucleotide identity to the prototype New Zealand strain and are regarded as antigenic variants of Whataroa virus.
Field studies in South Westland (1964âÂÂ1969) established that Whataroa virus circulates in an enzootic (natural, wildlife) cycle involving wild birds as vertebrate hosts and mosquitoes as vectors. The principal reservoir hosts are passerine birds, especially song thrushes (Turdus philomelos) and common blackbirds (Turdus merula), which showed the highest rates of infection in the Whataroa area. A fiveâÂÂyear serosurvey (1964âÂÂ1969) detected Whataroa virusâÂÂneutralising antibodies in about 15% of 4,300âÂÂ4,500 birds across 30 species; thrushes (and early on, blackbirds) had the highest and most persistent seroprevalence. An epizootic peaked in 1965âÂÂ1966 with monthly seropositivity up to about 70%. Most infections in birds are asymptomatic, and antibodies were detected each year, indicating persistent exposure without obvious illness. A 2022 national catalogue of viruses associated with indigenous Aotearoa New Zealand species identified Whataroa virus as the only case first reported from an indigenous host and later recorded in an introduced host species, consistent with spillover into introduced passerines.
Transmission is by endemic mosquitoes â primarily Culiseta tonnoiri and the vigilant mosquito (Culex pervigilans) â which feed predominantly on birds and thereby maintain the birdâÂÂmosquito cycle with limited spillover to mammals. Whataroa virus has been isolated from both species in the Whataroa region, confirming them as natural vectors. Under laboratory conditions, some Culiseta tonnoiri that fed on viraemic suckling mice transmitted the virus on subsequent feeds, corroborating a competent vector role. Experimental infections also showed high vector competence in Aedes australis (a laboratory analogue for South Westland species), with transmission typically only after about 17 days of extrinsic incubation at 20 ðC.
Whataroa virus is well adapted to South Westland's cool, temperate environment and replicates in mosquitoes at lower temperatures than other arboviruses studied at the time. By 20 ðC in laboratory studies, antigen appeared in some salivaryâÂÂgland cells within 18âÂÂ36 hours (depending on the infection route) and, once present, persisted for at least 122 days. Mosquitoes transmitted reliably only after high titres accumulated in salivary glands, consistent with an extended extrinsic incubation period at cooler temperatures. Enzootic maintenance appears local: birds often carried antibodies on emerging from winter, suggesting overwintering by lowâÂÂlevel chronic infection in birds and/or survival in dormant vectors. In experiments, the virus infected and persisted in the argasid tick Ornithodoros capensis, raising the possibility of arthropod reservoirs, though there is no field evidence of a continuous tickâÂÂborne cycle; the primary cycle is birdâÂÂmosquito.
Whataroa virus has a very limited known geographic range. Intensive ecological work in the 1960s identified a focal transmission zone in the Whataroa River valley and surrounding lowlands where key mosquito and bird species coâÂÂoccur. Despite extensive attempts during 1964âÂÂ1969 (no arbovirus was recovered from 3,800 bird blood samples or from about 63,000 mosquitoes collected locally) the serology showed sustained, local activity. Outside this focus, no other endemic mosquito-borne viruses were detected in New Zealand, and Whataroa virus remained geographically restricted despite the widespread presence of Culex pervigilans elsewhere in the country. A pilot genusâÂÂwide RTâÂÂPCR survey (2000âÂÂ2001) screened 6,293 mosquitoes from several regions (Kaipara Harbour, northern Hawke's Bay, Gisborne and the West Coast) and detected no Alphavirus RNA, demonstrating feasibility of molecular surveillance but reinforcing the focal nature of Whataroa virus. After a 40âÂÂyear gap with no monitoring, a 2010 survey at Whataroa again detected the virus (by molecular methods) in a small fraction of introduced thrushes and blackbirds (3/95; 3.2%); concurrent trapping did not detect it in mosquitoes, suggesting that bird sampling is the more sensitive indicator of lowâÂÂlevel circulation.
Beyond New Zealand, Whataroa virus (or very close variants) has been found in Australia. Several Alphavirus isolates from mosquitoes collected in New South Wales (1989âÂÂ1990) were 96âÂÂ97% identical in nucleotide sequence to the New Zealand prototype and were antigenically very similar, differing only in a few minor epitopes. This was the first isolation outside the original New Zealand focus and indicates a broader Australasian distribution, probably maintained in local birdâÂÂmosquito cycles. The route between New Zealand and Australia is uncertain â migratory birds or humanâÂÂassisted mosquito transport are plausible â but there is no record of outbreaks in Australia, and detection has been through specialised mosquito surveillance. A 2013âÂÂ2014 serosurvey of 287 horses in northern Queensland found rare WhataroaâÂÂlike neutralising antibodies (about 1.4% of properties), though crossâÂÂreaction with SindbisâÂÂlike alphaviruses could not be excluded; significance for Australian equids remains uncertain.
No confirmed human illnesses or outbreaks have been attributed to Whataroa virus in New Zealand or elsewhere. In 2005 a published correspondence debated possible human infection: Ministry of Health advisers suggested there was evidence of symptomless infection on the West Coast, whereas the original authors judged the data inconclusive and stated that no definite human cases had been confirmed in New Zealand. By analogy with related SindbisâÂÂgroup alphaviruses, any human infection would be expected to cause a mild influenzaâÂÂlike illness, if it occurs at all. Overall, humans appear to be incidental hosts at most, given the virus's preference for bird hosts and the birdâÂÂbiting habits of the endemic mosquito vectors. Modern surveys have not documented seroconversion or clinical cases despite longâÂÂterm environmental presence.
New Zealand public health guidance treats Whataroa virus as a low, residual risk. Its persistence shows that exotic arboviruses can establish silent enzootic cycles in local ecosystems. Surveillance interest continues, particularly under environmentalâÂÂchange scenarios; for example, the lateâÂÂ1990s incursion of the exotic southern saltmarsh mosquito (Aedes camptorhynchus; later eradicated) prompted concern about the potential for Ross River virus should competent vectors establish.